EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Patient experiences with hereditary cancer genetic test result release in the setting of the 21st Century Cures Act final rule

Cameron Bell, Samantha Pipito, Ashika Mani, Arravinth Anantharajah, Taylor Apostolico, Angela G Arnold, Jacqueline Cappadocia, Dana Farengo Clark, Melissa Heller, Jessica M Long, Derek Mann, Emma McKennon und 13 weitere

Familial Cancer · 2026

DOI: 10.1007/s10689-026-00613-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Familial Cancer, 2026. Verfasst von Cameron Bell und 24 weiteren Autor:innen. Beteiligte Einrichtung: Master of Science in Genetic Counseling Program, Perelman School of Medicine, University of Pennsylvania, PA, Philadelphia, USA. Hauptthemen laut MEDLINE: Genetic Testing, Genetic Counseling. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The 21st Century Cures Act Final Rule is a federal law recently implemented in the United States of America which prompted a practice shift among genetic counselors who historically disclosed genetic testing results by directly speaking with patients. Herein, we report participant experiences following a single-center’s approach of patients selecting provider-facilitated versus immediate release of hereditary cancer genetic testing results in the electronic health record preceding provider review. A voluntary survey was sent to patients who completed pre-test genetic counseling and hereditary cancer genetic testing within the University of Pennsylvania Health System. Responses were analyzed using descriptive statistics. Participants ( n = 153) were predominately White (77%), female (81%), obtained Master’s or Doctoral degrees (47%), and a median age of 60 (range 22–81). Participants across both result release cohorts did not differ in demographics, indication for testing, answers to knowledge-based questions or initial emotional responses. When asked about release preference for future genetic testing, most participants preferred provider-facilitated electronic portal message or a phone call. Of the participants who initially elected immediate release, only 18% (20/113) would again elect immediate release for future genetic tests. Participants across results release cohorts predominately elect for provider-facilitated release for future genetic testing, suggesting provider involvement may benefit patient disclosure experience.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TestingGenetic CounselingHumansFemaleMiddle AgedAdultAgedReturn of Individual Research ResultsMaleUnited StatesAged, 80 and overYoung AdultSurveys and QuestionnairesElectronic Health Records

Stichwörter der Autor:innen

21st Century Cures ActElectronic health record (EHR)Genetic counselingHereditary cancer genetic testingPatient-centered careResults communication

Autor:innen und Institutionen

  • Master of Science in Genetic Counseling Program, Perelman School of Medicine, University of Pennsylvania, PA, Philadelphia, USA.
  • Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Health System, Philadelphia, PA, 19104, USA.
  • Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Division of Translational Medicine & Human Genetics, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Division of Gastroenterology and Hepatology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Health System, Philadelphia, PA, 19104, USA. jebra@pennmedicine.upenn.edu.

ORCID-Profile: Jessica E Ebrahimzadeh

Zitieren

APA

Bell, C., Pipito, S., Mani, A., Anantharajah, A., Apostolico, T., Arnold, A. G., Cappadocia, J., Clark, D. F., Heller, M., Long, J. M., Mann, D., McKennon, E., Mercado, J., Powers, J., Raper, A., Spielman, K., Katona, B. W., Maxwell, K., Nathanson, K. L., …, & Ebrahimzadeh, J. E. (2026). Patient experiences with hereditary cancer genetic test result release in the setting of the 21st Century Cures Act final rule. Familial Cancer. https://doi.org/10.1007/s10689-026-00613-9

Vancouver

Bell C, Pipito S, Mani A, Anantharajah A, Apostolico T, Arnold AG, et al. Patient experiences with hereditary cancer genetic test result release in the setting of the 21st Century Cures Act final rule. Familial Cancer. 2026. doi:10.1007/s10689-026-00613-9

BibTeX
@article{Bell2026,
  author = {Bell, Cameron and Pipito, Samantha and Mani, Ashika and Anantharajah, Arravinth and Apostolico, Taylor and Arnold, Angela G and Cappadocia, Jacqueline and Clark, Dana Farengo and Heller, Melissa and Long, Jessica M and Mann, Derek and McKennon, Emma and Mercado, Joanna and Powers, Jacquelyn and Raper, Anna and Spielman, Kelsey and Katona, Bryson W and Maxwell, Kara and Nathanson, Katherine L and Rohanizadegan, Mersedeh and Shah, Payal D and Bradbury, Angela and Domchek, Susan M and Mueller, Rebecca and Ebrahimzadeh, Jessica E},
  title = {Patient experiences with hereditary cancer genetic test result release in the setting of the 21st Century Cures Act final rule},
  journal = {Familial Cancer},
  year = {2026},
  doi = {10.1007/s10689-026-00613-9}
}
Kostenlos starten →